Modafinil is a wakefulness-promoting agent indicated for the treatment of narcolepsy, shift work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea. Beyond these approved indications, modafinil is also widely used off-label as a cognitive enhancer.

To support law enforcement efforts, AccuSift provides high-performance competitive antibody pairs for modafinil detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.

Sensitivity: ELISA LOD: 1.5 ng/mL